Selected research
Market Outlook & Growth Opportunities
Global Biological Products Safety Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Biological Products Safety Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Biological Products Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biological Products Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biological Products Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Biological Products Safety Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Biological Products Safety Testing Service market include Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell, WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI) and Suzhou Liangchen Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Biological Products Safety Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biological Products Safety Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biological Products Safety Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biological Products Safety Testing Service market.
Biological Products Safety Testing Service Segment by Company
Eurofins Scientific
SGS
Q2 Solutions
Samsung Biologics
Texcell
WuXi Biologics
Wuhan Canvest Biotechnology
Centre Testing International (CTI)
Suzhou Liangchen Biotechnology
JADE Biomedical
Standard Testing Group
Sino Tech World Biologicals
CAS Testing Technical Services
NTEK
Sino Biological
Miracle Points
Suzhou Cefety Bioscience
Zhejiang Hengyu Biological
Merck
Charles River Laboratories
Sartorius
Biological Products Safety Testing Service Segment by Type
Raw Materials
Viral Banks
Cell Banks
Others
Biological Products Safety Testing Service Segment by Application
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Academic and Research Institutions
Biological Products Safety Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biological Products Safety Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Biological Products Safety Testing Service key companies, revenue, market share, and recent developments.
3. To split the Biological Products Safety Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Biological Products Safety Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biological Products Safety Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Biological Products Safety Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Products Safety Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biological Products Safety Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Products Safety Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biological Products Safety Testing Service industry.
Chapter 3: Detailed analysis of Biological Products Safety Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Biological Products Safety Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Biological Products Safety Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Raw Materials
- Viral Banks
- Cell Banks
- Others
Applications
- Pharmaceutical and Biotechnology Companies
- CROs and CDMOs
- Academic and Research Institutions
Companies covered
- Eurofins Scientific
- SGS
- Q2 Solutions
- Samsung Biologics
- Texcell
- WuXi Biologics
- Wuhan Canvest Biotechnology
- Centre Testing International (CTI)
- Suzhou Liangchen Biotechnology
- JADE Biomedical
- Standard Testing Group
- Sino Tech World Biologicals
- CAS Testing Technical Services
- NTEK
- Sino Biological
- Miracle Points
- Suzhou Cefety Bioscience
- Zhejiang Hengyu Biological
- Merck
- Charles River Laboratories
- Sartorius
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biological Products Safety Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biological Products Safety Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biological Products Safety Testing Service Market Dynamics
- 2.1 Biological Products Safety Testing Service Industry Trends
- 2.2 Biological Products Safety Testing Service Industry Drivers
- 2.3 Biological Products Safety Testing Service Industry Opportunities and Challenges
- 2.4 Biological Products Safety Testing Service Industry Restraints
3 Biological Products Safety Testing Service Market by Company
- 3.1 Global Biological Products Safety Testing Service Company Revenue Ranking in 2025
- 3.2 Global Biological Products Safety Testing Service Revenue by Company (2021-2026)
- 3.3 Global Biological Products Safety Testing Service Company Ranking (2024-2026)
- 3.4 Global Biological Products Safety Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global Biological Products Safety Testing Service Company Product Type and Application
- 3.6 Global Biological Products Safety Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Biological Products Safety Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Biological Products Safety Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Biological Products Safety Testing Service Market by Type
- 4.1 Biological Products Safety Testing Service Type Introduction
- 4.1.1 Raw Materials
- 4.1.2 Viral Banks
- 4.1.3 Cell Banks
- 4.1.4 Others
- 4.2 Global Biological Products Safety Testing Service Sales Value by Type
- 4.2.1 Global Biological Products Safety Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biological Products Safety Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Biological Products Safety Testing Service Sales Value Share by Type (2021-2032)
5 Biological Products Safety Testing Service Market by Application
- 5.1 Biological Products Safety Testing Service Application Introduction
- 5.1.1 Pharmaceutical and Biotechnology Companies
- 5.1.2 CROs and CDMOs
- 5.1.3 Academic and Research Institutions
- 5.2 Global Biological Products Safety Testing Service Sales Value by Application
- 5.2.1 Global Biological Products Safety Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biological Products Safety Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Biological Products Safety Testing Service Sales Value Share by Application (2021-2032)
6 Biological Products Safety Testing Service Regional Value Analysis
- 6.1 Global Biological Products Safety Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biological Products Safety Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Biological Products Safety Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Biological Products Safety Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biological Products Safety Testing Service Sales Value (2021-2032)
- 6.3.2 North America Biological Products Safety Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Biological Products Safety Testing Service Sales Value (2021-2032)
- 6.4.2 Europe Biological Products Safety Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Biological Products Safety Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Biological Products Safety Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Biological Products Safety Testing Service Sales Value (2021-2032)
- 6.6.2 South America Biological Products Safety Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Biological Products Safety Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Biological Products Safety Testing Service Sales Value Share by Country, 2025 VS 2032
7 Biological Products Safety Testing Service Country-level Value Analysis
- 7.1 Global Biological Products Safety Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biological Products Safety Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Biological Products Safety Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Biological Products Safety Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Biological Products Safety Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Biological Products Safety Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Biological Products Safety Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Eurofins Scientific
- 8.1.1 Eurofins Scientific Company Information
- 8.1.2 Eurofins Scientific Business Overview
- 8.1.3 Eurofins Scientific Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Eurofins Scientific Biological Products Safety Testing Service Product Portfolio
- 8.1.5 Eurofins Scientific Recent Developments
- 8.2 SGS
- 8.2.1 SGS Company Information
- 8.2.2 SGS Business Overview
- 8.2.3 SGS Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 SGS Biological Products Safety Testing Service Product Portfolio
- 8.2.5 SGS Recent Developments
- 8.3 Q2 Solutions
- 8.3.1 Q2 Solutions Company Information
- 8.3.2 Q2 Solutions Business Overview
- 8.3.3 Q2 Solutions Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Q2 Solutions Biological Products Safety Testing Service Product Portfolio
- 8.3.5 Q2 Solutions Recent Developments
- 8.4 Samsung Biologics
- 8.4.1 Samsung Biologics Company Information
- 8.4.2 Samsung Biologics Business Overview
- 8.4.3 Samsung Biologics Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Samsung Biologics Biological Products Safety Testing Service Product Portfolio
- 8.4.5 Samsung Biologics Recent Developments
- 8.5 Texcell
- 8.5.1 Texcell Company Information
- 8.5.2 Texcell Business Overview
- 8.5.3 Texcell Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Texcell Biological Products Safety Testing Service Product Portfolio
- 8.5.5 Texcell Recent Developments
- 8.6 WuXi Biologics
- 8.6.1 WuXi Biologics Company Information
- 8.6.2 WuXi Biologics Business Overview
- 8.6.3 WuXi Biologics Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 WuXi Biologics Biological Products Safety Testing Service Product Portfolio
- 8.6.5 WuXi Biologics Recent Developments
- 8.7 Wuhan Canvest Biotechnology
- 8.7.1 Wuhan Canvest Biotechnology Company Information
- 8.7.2 Wuhan Canvest Biotechnology Business Overview
- 8.7.3 Wuhan Canvest Biotechnology Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Wuhan Canvest Biotechnology Biological Products Safety Testing Service Product Portfolio
- 8.7.5 Wuhan Canvest Biotechnology Recent Developments
- 8.8 Centre Testing International (CTI)
- 8.8.1 Centre Testing International (CTI) Company Information
- 8.8.2 Centre Testing International (CTI) Business Overview
- 8.8.3 Centre Testing International (CTI) Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Centre Testing International (CTI) Biological Products Safety Testing Service Product Portfolio
- 8.8.5 Centre Testing International (CTI) Recent Developments
- 8.9 Suzhou Liangchen Biotechnology
- 8.9.1 Suzhou Liangchen Biotechnology Company Information
- 8.9.2 Suzhou Liangchen Biotechnology Business Overview
- 8.9.3 Suzhou Liangchen Biotechnology Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Suzhou Liangchen Biotechnology Biological Products Safety Testing Service Product Portfolio
- 8.9.5 Suzhou Liangchen Biotechnology Recent Developments
- 8.10 JADE Biomedical
- 8.10.1 JADE Biomedical Company Information
- 8.10.2 JADE Biomedical Business Overview
- 8.10.3 JADE Biomedical Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 JADE Biomedical Biological Products Safety Testing Service Product Portfolio
- 8.10.5 JADE Biomedical Recent Developments
- 8.11 Standard Testing Group
- 8.11.1 Standard Testing Group Company Information
- 8.11.2 Standard Testing Group Business Overview
- 8.11.3 Standard Testing Group Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Standard Testing Group Biological Products Safety Testing Service Product Portfolio
- 8.11.5 Standard Testing Group Recent Developments
- 8.12 Sino Tech World Biologicals
- 8.12.1 Sino Tech World Biologicals Company Information
- 8.12.2 Sino Tech World Biologicals Business Overview
- 8.12.3 Sino Tech World Biologicals Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Sino Tech World Biologicals Biological Products Safety Testing Service Product Portfolio
- 8.12.5 Sino Tech World Biologicals Recent Developments
- 8.13 CAS Testing Technical Services
- 8.13.1 CAS Testing Technical Services Company Information
- 8.13.2 CAS Testing Technical Services Business Overview
- 8.13.3 CAS Testing Technical Services Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 CAS Testing Technical Services Biological Products Safety Testing Service Product Portfolio
- 8.13.5 CAS Testing Technical Services Recent Developments
- 8.14 NTEK
- 8.14.1 NTEK Company Information
- 8.14.2 NTEK Business Overview
- 8.14.3 NTEK Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 NTEK Biological Products Safety Testing Service Product Portfolio
- 8.14.5 NTEK Recent Developments
- 8.15 Sino Biological
- 8.15.1 Sino Biological Company Information
- 8.15.2 Sino Biological Business Overview
- 8.15.3 Sino Biological Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 Sino Biological Biological Products Safety Testing Service Product Portfolio
- 8.15.5 Sino Biological Recent Developments
- 8.16 Miracle Points
- 8.16.1 Miracle Points Company Information
- 8.16.2 Miracle Points Business Overview
- 8.16.3 Miracle Points Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Miracle Points Biological Products Safety Testing Service Product Portfolio
- 8.16.5 Miracle Points Recent Developments
- 8.17 Suzhou Cefety Bioscience
- 8.17.1 Suzhou Cefety Bioscience Company Information
- 8.17.2 Suzhou Cefety Bioscience Business Overview
- 8.17.3 Suzhou Cefety Bioscience Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Suzhou Cefety Bioscience Biological Products Safety Testing Service Product Portfolio
- 8.17.5 Suzhou Cefety Bioscience Recent Developments
- 8.18 Zhejiang Hengyu Biological
- 8.18.1 Zhejiang Hengyu Biological Company Information
- 8.18.2 Zhejiang Hengyu Biological Business Overview
- 8.18.3 Zhejiang Hengyu Biological Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Zhejiang Hengyu Biological Biological Products Safety Testing Service Product Portfolio
- 8.18.5 Zhejiang Hengyu Biological Recent Developments
- 8.19 Merck
- 8.19.1 Merck Company Information
- 8.19.2 Merck Business Overview
- 8.19.3 Merck Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.19.4 Merck Biological Products Safety Testing Service Product Portfolio
- 8.19.5 Merck Recent Developments
- 8.20 Charles River Laboratories
- 8.20.1 Charles River Laboratories Company Information
- 8.20.2 Charles River Laboratories Business Overview
- 8.20.3 Charles River Laboratories Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.20.4 Charles River Laboratories Biological Products Safety Testing Service Product Portfolio
- 8.20.5 Charles River Laboratories Recent Developments
- 8.21 Sartorius
- 8.21.1 Sartorius Company Information
- 8.21.2 Sartorius Business Overview
- 8.21.3 Sartorius Biological Products Safety Testing Service Revenue and Gross Margin (2021-2026)
- 8.21.4 Sartorius Biological Products Safety Testing Service Product Portfolio
- 8.21.5 Sartorius Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst